291 related articles for article (PubMed ID: 11337032)
21. Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease.
Duty S
Br J Pharmacol; 2010 Sep; 161(2):271-87. PubMed ID: 20735415
[TBL] [Abstract][Full Text] [Related]
22. Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease.
Amalric M
Curr Opin Pharmacol; 2015 Feb; 20():29-34. PubMed ID: 25462289
[TBL] [Abstract][Full Text] [Related]
23. Activation of group III mGluRs inhibits GABAergic and glutamatergic transmission in the substantia nigra pars reticulata.
Wittmann M; Marino MJ; Bradley SR; Conn PJ
J Neurophysiol; 2001 May; 85(5):1960-8. PubMed ID: 11353013
[TBL] [Abstract][Full Text] [Related]
24. Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease.
Sgambato-Faure V; Cenci MA
Prog Neurobiol; 2012 Jan; 96(1):69-86. PubMed ID: 22075179
[TBL] [Abstract][Full Text] [Related]
25. A system-level mathematical model of Basal Ganglia motor-circuit for kinematic planning of arm movements.
Salimi-Badr A; Ebadzadeh MM; Darlot C
Comput Biol Med; 2018 Jan; 92():78-89. PubMed ID: 29156412
[TBL] [Abstract][Full Text] [Related]
26. Modeling basal ganglia for understanding Parkinsonian reaching movements.
Magdoom KN; Subramanian D; Chakravarthy VS; Ravindran B; Amari S; Meenakshisundaram N
Neural Comput; 2011 Feb; 23(2):477-516. PubMed ID: 21105828
[TBL] [Abstract][Full Text] [Related]
27. Dopaminergic Modulation of Synaptic Integration and Firing Patterns in the Rat Entopeduncular Nucleus.
Lavian H; Almog M; Madar R; Loewenstern Y; Bar-Gad I; Okun E; Korngreen A
J Neurosci; 2017 Jul; 37(30):7177-7187. PubMed ID: 28652413
[TBL] [Abstract][Full Text] [Related]
28. Glutamate and Parkinson's disease.
Blandini F; Porter RH; Greenamyre JT
Mol Neurobiol; 1996 Feb; 12(1):73-94. PubMed ID: 8732541
[TBL] [Abstract][Full Text] [Related]
29. Changes in metabotropic glutamate receptor 1-8 gene expression in the rodent basal ganglia motor loop following lesion of the nigrostriatal tract.
Messenger MJ; Dawson LG; Duty S
Neuropharmacology; 2002 Aug; 43(2):261-71. PubMed ID: 12213280
[TBL] [Abstract][Full Text] [Related]
30. Striatopallidal Neuron NMDA Receptors Control Synaptic Connectivity, Locomotor, and Goal-Directed Behaviors.
Lambot L; Chaves Rodriguez E; Houtteman D; Li Y; Schiffmann SN; Gall D; de Kerchove d'Exaerde A
J Neurosci; 2016 May; 36(18):4976-92. PubMed ID: 27147651
[TBL] [Abstract][Full Text] [Related]
31. The organization of the basal ganglia functional connectivity network is non-linear in Parkinson's disease.
Rodriguez-Sabate C; Morales I; Lorenzo JN; Rodriguez M
Neuroimage Clin; 2019; 22():101708. PubMed ID: 30763902
[TBL] [Abstract][Full Text] [Related]
32. Nitric oxide modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.
Pierucci M; Galati S; Valentino M; Di Matteo V; Benigno A; Pitruzzella A; Muscat R; Di Giovanni G
CNS Neurol Disord Drug Targets; 2011 Nov; 10(7):777-91. PubMed ID: 21999732
[TBL] [Abstract][Full Text] [Related]
33. Group III metabotropic glutamate-receptor-mediated modulation of excitatory transmission in rodent substantia nigra pars compacta dopamine neurons.
Valenti O; Mannaioni G; Seabrook GR; Conn PJ; Marino MJ
J Pharmacol Exp Ther; 2005 Jun; 313(3):1296-304. PubMed ID: 15761115
[TBL] [Abstract][Full Text] [Related]
34. Dopamine modulates the function of group II and group III metabotropic glutamate receptors in the substantia nigra pars reticulata.
Wittmann M; Marino MJ; Conn PJ
J Pharmacol Exp Ther; 2002 Aug; 302(2):433-41. PubMed ID: 12130700
[TBL] [Abstract][Full Text] [Related]
35. Lack of depotentiation at basal ganglia output neurons in PD patients with levodopa-induced dyskinesia.
Prescott IA; Liu LD; Dostrovsky JO; Hodaie M; Lozano AM; Hutchison WD
Neurobiol Dis; 2014 Nov; 71():24-33. PubMed ID: 25116960
[TBL] [Abstract][Full Text] [Related]
36. Striatal information signaling and integration in globus pallidus: timing matters.
Chan CS; Surmeier DJ; Yung WH
Neurosignals; 2005; 14(6):281-9. PubMed ID: 16772731
[TBL] [Abstract][Full Text] [Related]
37. [Somatotopy in the basal ganglia].
Nanbu A
Brain Nerve; 2009 Dec; 61(12):1383-94. PubMed ID: 20034305
[TBL] [Abstract][Full Text] [Related]
38. Balance of transmitter activities in the basal ganglia loops.
Schmidt WJ
J Neural Transm Suppl; 1995; 46():67-76. PubMed ID: 8821042
[TBL] [Abstract][Full Text] [Related]
39. Interaction of adenosine receptors with other receptors from therapeutic perspective in Parkinson's disease.
Morin N; Di Paolo T
Int Rev Neurobiol; 2014; 119():151-67. PubMed ID: 25175965
[TBL] [Abstract][Full Text] [Related]
40. Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease.
Miguelez C; Morera-Herreras T; Torrecilla M; Ruiz-Ortega JA; Ugedo L
Front Neural Circuits; 2014; 8():21. PubMed ID: 24672433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
